Bioinformatics Market Report 2025

This Bioinformatics market report provides a comprehensive analysis of the market’s characteristics, size, and growth, including segmentation, regional and country-level breakdowns, competitive landscape, market shares, trends, and strategies. It also tracks historical and forecasted market growth across various geographies.

The bioinformatics market size has grown rapidly in recent years. It will grow from $16.54 billion in 2024 to $18.62 billion in 2025 at a compound annual growth rate (CAGR) of 12.6%. The growth in the historic period can be attributed to genomic sequencing advancements, biomedical research growth, drug discovery and development, personalized medicine, agriculture and biotechnology.

The bioinformatics market size is expected to see rapid growth in the next few years. It will grow to $32.76 billion in 2029 at a compound annual growth rate (CAGR) of 15.2%. The growth in the forecast period can be attributed to advancements in omics technologies, artificial intelligence (ai) and machine learning, data integration and cloud computing, biomarker discovery and diagnostics, interdisciplinary collaboration. Major trends in the forecast period include genomic data explosion, personalized medicine, machine learning and ai, drug discovery and development.

The bioinformatics market is set to witness substantial growth, driven by the expanding pharmaceutical industry. The pharmaceutical sector, responsible for drug discovery, development, and production, both in public and private domains, relies heavily on bioinformatics. It enhances the drug development process, reduces costs, and elevates the efficacy and safety of drug therapies. For example, in May 2024, according to GOV.UK, a UK-based government department, the UK life sciences industry generated £108.1 billion in turnover during 2021/22, reflecting a 13% increase from the £95.9 billion turnover (adjusted for 2021/22 prices) recorded in 2020/21. This growth in the pharmaceutical industry is contributing to the expansion of the bioinformatics market.

Leading companies in the bioinformatics market are focusing on developing advanced technological solutions, such as bioinformatics platforms, to enhance data analysis capabilities, improve precision in personalized medicine, and accelerate drug discovery. A bioinformatics platform is a software system or an integrated suite of tools designed to manage, analyze, and interpret biological data, such as genomic, proteomic, and metabolomic information, to support research and clinical decision-making. For example, in February 2024, Metabolon, Inc., a US-based biotechnology company, launched an integrated bioinformatics platform. This platform provides a comprehensive set of analytical tools designed to simplify metabolomics research, allowing users to perform complex analyses with ease. Notable features include advanced visualization tools like volcano plots and principal component analysis (PCA), along with innovative biomarker lenses that offer targeted insights into specific pathways and diseases.

Major companies within the bioinformatics market are focusing on the expansion of bioinformatics platforms to effectively manage vast biotech data, facilitating accelerated scientific discovery. These comprehensive platforms are software solutions that encompass a complete suite of tools and services tailored for biological data management and analysis. For instance, in June 2022, LatchBio, a US-based biotechnology research startup, unveiled an all-encompassing bioinformatics platform tailored to handle large-scale biotech data, promoting quicker scientific breakthroughs. This platform simplifies collaborative data analysis and visualization for a broad spectrum of professionals, including biologists, bioinformaticians, and computational biologists.

In May 2022, ZS Associates, a US-based management consulting and technology firm, executed the acquisition of Intomics A/S for an undisclosed sum. This strategic acquisition aims to reinforce ZS Associates' commitment to drug discovery, enhancing drug development success rates and diversifying its service offerings. Intomics A/S, headquartered in Denmark, specializes in bioinformatics and systems biology, aligning seamlessly with the broader goals of ZS Associates.

Major companies operating in the bioinformatics market include Agilent Technologies Inc., Illumina Inc., QIAGEN NV, Affymetrix Inc., Thermo Fisher Scientific Inc., BGI Group, Dassault Systems SE, Eurofins Scientific SE, Bruker Corporation, Biomax Informatix AG, DNASTAR Inc., Partek Inc., Geneva Bioinformatics SA, Perkinelmer Inc., Accelrys Inc., Nonlinear Dynamics SA, Quest Diagnostics Inc., Sophia Genetics SA, Waters Corporation, Permin Elmer Inc., Celera Corporation, Tripos Inc., Helicos Biosciences Incorporation, IBM Life Sciences, Applied Biologicals Materials Inc., Life Technologies Corporation, GNS Healthcare Inc., DNAnexus Inc., Intrexon Bioinformatics Germany GmbH, Syapse Inc.

Bioinformatics, closely linked to genetics and genomics, harnesses computer technology to collect, store, analyze, and disseminate biological information and data, encompassing DNA and amino acid sequences, as well as associated annotations.

The primary categories of products and services within the field of bioinformatics encompass knowledge management tools, data analysis platforms, and a range of associated services. Knowledge management tools serve as essential technologies for organizations, enabling the sharing of information both internally and externally. Bioinformatics applications span various domains, including metabolomics, molecular phylogenetics, transcriptomics, proteomics, chemoinformatics, and genomics. These applications find use across diverse industries, including pharmaceuticals, animal studies, agriculture, forensic science, and other end-user segments.

The bioinformatics market research report is one of a series of new reports that provides bioinformatics market statistics, including bioinformatics industry global market size, regional shares, competitors with a bioinformatics market share, detailed bioinformatics market segments, market trends and opportunities, and any further data you may need to thrive in the bioinformatics industry. This bioinformatics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

North America was the largest region in the bioinformatics market in 2024. Western Europe was the second largest region in the bioinformatics market analysis. The regions covered in the bioinformatics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the bioinformatics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The bioinformatics market includes revenues earned by entities by providing solutions which combine computer programming, information engineering, mathematics, and statistics to analyze biological data for drug discovery and preclinical studies. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.